News

OPINION: Ngugi, Where Is The Light?

Published

7 months ago

June 3, 2025

By Lasisi Olagunju

My generation met him famous. His first novels he wrote as an undergraduate. One of them was the hugely popular ‘Weep Not, Child’; another was ‘The River Between.’ He was James Ngũgĩ, then he became James Thiong’o Ngũgĩ, then he stepped out fully and became Ngũgĩ wa Thiong’o.

The African writer from Kenya who died last week worked really hard to repudiate everything that he thought oppressed him. He took out his scalpel and cut open the name he bore. He dropped the foreign and picked a labyrinthine label from his ancestral pouch. The language of his art was next. With the English language, he wrote himself to fame, then he dropped English and started writing in Gikuyu. If you thought Gikuyu wasn’t global enough, you could translate his works to English or whatever European language you wanted. Ngugi was rigid in his conviction. Was his muse playing with irony or contradiction or what figure of speech best describes his experiment with life? He dropped everything the oppressor brought to Africa. Yet, when death came last week, it met him in the very land that epitomises those things he ran away from – the United States.

Some forty-something years ago, ‘Weep Not, Child’ was prescribed for our school certificate exams. Some of us soon found in it much more than what WAEC said it was. It is a book of light; a writ of struggle and liberation. We ate and chewed and swallowed and digested it. From that story and the next and the next, I read in Ngugi an optimistic soldier of justice. He believed in the inevitable victory of light over darkness. ‘Weep Not, Child’ took its title from Walt Whitman’s ‘On The Beach At Night’. It is in that poem that the challenged child is told not to weep because “The ravening clouds shall not long be victorious” and “shall not long possess the sky.” But how long is not long enough? That book was written over 60 years ago. The sky is still possessed by the clouds.

MORE FROM THE AUTHOR: OPINION: Nigerian Beggars In Ghana

The writer loved his country and gave it his all. But his ‘free’ country soon showed him the taste of pepper. ‘Independence’ has remained what it parades: an exchange of foreign oppression for domestic repression. Jomo Kenyatta is knighted in ‘Weep Not, Child’ as the hope of the oppressed. He became president and blighted the tall and the short who placed their hope in him. Ngugi was a victim. His recollections say: “writers were not spared. In 1969, a leading poet, Abdulatif Abdalla, was imprisoned for writing a pamphlet entitled Kenya twendapi? (‘Kenya, where are we heading to?’) It was my turn in 1977 for my play, ‘I Will Marry When I Want’, and novel, ‘Petals of Blood’. I was in a maximum security prison in 1978 when Kenyatta died and his vice-president, Daniel Arap Moi, took over. Though I was happy that Moi released me three months after his ascension to power, I soon realized that he had emptied the jails of hundreds of Kenyatta’s political prisoners to make room for thousands of his own. Where Kenyatta had imprisoned me for my writing, Moi sent three truckloads of armed policemen to raze to the ground the community theatre where I worked, eventually forcing me – and many others – into exile.”

That was his Kenya; and it was not just his Kenya. It was and is Africa. Dark Africa has “Two laws. Two justices. One law and one justice protects the man of property, of wealth and the foreign exploiter. Another law and another justice silences the poor, the hungry, our people.” No darkness could be darker than what is described here by Ngugi in ‘The Trial of Dedan Kimathi’. Yet, throughout his life, the man kept talking about light defeating darkness.

Even as dusk approached and he was going, going, Ngugi still wrote optimism in 2020. He said that Wanjikũ, his Gĩkũyũ mother, used to tell him: Gũtirĩ ũtukũ ũtakĩa: No night is so Dark that, / It will not end in Dawn, / Or simply put, / Every night ends with dawn./ Gũtirĩ ũtukũ ũtakĩa…”

Language frees and can also enslave. Ngugi said it contains the seed of life. It is a sword of freedom and can be a tool in the hand of the oppressor. The writer believed so and I agree with him. He says: “If you know all the languages of the world and you do not know your mother tongue, the language of your culture, that is enslavement. On the other hand, if you know your mother tongue, the language of your culture and you add all the languages of the world to it, that is empowerment.” He also spoke about labels. Addressing a group of young Africans, he interrogated ‘tribe’ as a lexical item of racial interest. “Tribalism is a colonial invention”, he said, and asked: “Why would 250,000 Icelanders be called a nation and ten million Yorubas are called a tribe, and not a nation?.”

MORE FROM THE AUTHOR: OPINION: JAMB, Glitches And An Inter-tribal War

Ngũgĩ wrote seven novels, at least five plays, more than four memoirs, over eight collections of essays, and several children’s books. You are very familiar with ‘Weep Not, Child’ (1964), ‘The River Between’ (1965), ‘A Grain of Wheat’ (1967) and ‘Petals of Blood’ (1977). Yet the man almost denied us the benefit of some of his critical stories. His ‘Devil on the Cross’, published in 1980 was originally in Gikuyu as Caitaani Mutharaba-Ini. ‘Matigari’, another novel published in 1986 was also written originally in Gikuyu; the same with ‘Wizard of the Crow’ originally in Gikuyu as ‘Mũrogi wa Kagogo’. Why did he do that? “When you use a language, you are also choosing an audience …. When I used English, I was choosing an English-speaking audience…” He said in a February 1996 interview in India. A global citizen sits in the US and writes in a Kenyan language! What kind of rebellion informed that? What Kikuyu audience was the writer targeting in America? I wished I could ask him to provide answers to those queries.

The challenges he faced were matched by the sheer strength of his character, his resilient spirit. To him, “Life, struggle, even amidst pain and blood and poverty, seemed beautiful.” His life mirrored the blistered feet on Africa’s sherd roads, stubborn and untired. In ‘The River Between’, we encounter Ngugi’s river, the Honia, which he says, “meant cure, or bring-back-to-life.” That river never dried and “seemed to possess a strong will to live, scorning droughts and weather changes. And it went on in the same way, never hurrying, never hesitating.” I think that says something prophetic of the tardy black man as he soon became marooned between the drought of the past and the pestilence of the present. For most of his 89 years, Ngugi stood at the bank of River Africa watching “as it gracefully, and without any apparent haste, wound its way down the valley, like a snake.”

‘Darkness Falls’ is the title of a critical part of ‘Weep Not, Child’. The storyteller fought darkness on all fronts. He still fights. For Ngugi Wa Thiong’o, writer of light, dusk dawned last week. As he ebbed away, one could imagine the horror in his eyes as he watched Africa’s inheritors do what the rains did in ‘The River Between’: “Carrying away the soil. Corroding, eating away the earth. Stealing the land.”

Africa’s predators are audacious; they do their thing right in the open marketplace. He cried out: “How do you satirise their utterances and claims when their own words beat all fictional exaggerations?” He asked in his ‘Decolonising the Mind: The Politics of Language in African Literature.’ But he was still full of hope that light would drive out darkness.

Hope appears to me his greatest asset. Till his canary stopped chirping, he never stopped asking the African child not to weep. He insisted that kisses of spoken and written words would soon birth a dawn of justice. In spite of all the death and destruction we see all over, he still believed that “This darkness too will pass away” and that “We shall meet again and again /And talk about Darkness and Dawn / Sing and laugh, maybe even hug…In the light of the Darkness and the new Dawn.” I do not know the peg on which his optimism was anchored. What we see is every new decade bringing darker misery. But we must listen to him. He was an elder who saw far even while seated. So, I ask him: Ngugi, before you cross the river, tell us: when is the new Dawn? And, where is the light you predicted? May your soul Rest In Peace.

News

Togo, Niger, Benin Owe Nigeria Over $17.8m For Supplied Electricity – NERC

Published

2 hours ago

January 8, 2026

Editor

Nigeria’s electricity regulator has disclosed that three neighbouring countries, Togo, Niger and Benin, are indebted to Nigeria to the tune of $17.8 million, equivalent to more than N25 billion at prevailing exchange rates, for power supplied under bilateral electricity agreements.

The Nigerian Electricity Regulatory Commission, NERC, made this known in its Third Quarter 2025 report, which reviewed market performance within the Nigerian Electricity Supply Industry, NESI.

According to the report, the international customers were billed a total of $18.69 million by the Market Operator for electricity supplied during the third quarter of 2025. However, only $7.125 million was paid, leaving an unpaid balance of $11.56 million for the period under review.

NERC also revealed that the same international offtakers had outstanding legacy debts amounting to $14.7 million from previous quarters. Of this amount, $7.84 million was settled, leaving a residual balance of $6.23 million.

When combined with the Q3 2025 shortfall, the total outstanding debt stood at $17.8 million, which translates to about N25.36 billion at an exchange rate of N1,425 to one US dollar.

The regulator identified the international electricity customers as Compagnie Énergie Électrique du Togo, Société Béninoise d’Énergie Électrique of Benin Republic, and Société Nigérienne d’Électricité of Niger Republic.

NERC stated that the three utilities collectively paid just $7.125 million against the $18.69 million invoice issued for electricity supplied in the third quarter, resulting in a remittance performance of 38.09 per cent.

This meant that more than half of the billed amount remained unpaid at the close of the quarter.

The commission explained that the electricity exported to the three countries was generated by grid-connected Nigerian generation companies and delivered through cross-border bilateral power supply arrangements.

By contrast, NERC reported a stronger payment performance among domestic bilateral customers. According to the report, local customers paid N3.19 billion out of the N3.64 billion invoiced for the same quarter, representing a remittance rate of 87.61 per cent.

The regulator further noted that some bilateral customers, both international and domestic, made additional payments to offset outstanding invoices from earlier quarters.

Specifically, the Market Operator received $7.84 million from international customers and N1.3 billion from domestic customers in settlement of previous obligations.

Beyond bilateral transactions, NERC disclosed that Nigeria’s 11 electricity distribution companies remitted a total of N381.29 billion to the Nigerian Bulk Electricity Trading Plc and the Market Operator in the third quarter of 2025. This was out of a cumulative invoice of N400.48 billion, translating to an overall remittance performance of 95.21 per cent.

The commission said the figures were derived from reconciled market settlement data submitted as of December 18, 2025, as part of its statutory evaluation of the commercial health and performance of the electricity market.

News

Expert Identify Foods That Increase Hypertension Medication’s Effectiveness

Published

10 hours ago

January 8, 2026

Editor

Hypertension remains one of the leading causes of premature death worldwide, contributing significantly to heart disease, stroke, and kidney failure. Despite the availability of effective antihypertensive drugs, long-term control of high blood pressure is often challenging because of drug resistance, side effects, and poor adherence.

This has fueled growing scientific interest in complementary strategies that can enhance drug efficacy while minimising toxicity. One promising approach is the combination of conventional antihypertensive medications with herbs and spices in many kitchens.

Recent evidence suggests that augmenting modern antihypertensive drugs with foods rich in p-coumaric acid, a naturally occurring phenolic acid, may offer a novel and effective strategy for blood pressure control.

Phenolic compounds, commonly found in fruits, vegetables, whole grains, and legumes, are known for their antioxidant, anti-inflammatory, and blood vessel–protective properties.

In a study, researchers investigated the combined effects of lisinopril, a widely used antihypertensive drugs and p-coumaric acid on hypertension.

They reported in the Comparative Clinical Pathology that p-coumaric acid enhance the antihypertensive action of lisinopril, potentially allowing for improved blood pressure control without increasing drug dosage.

The study used an established animal model in which hypertension was induced in rats through oral administration of L-NAME, a compound known to suppress nitric oxide production and raise blood pressure.

Following the induction of hypertension, the animals were treated for 14 days with p-coumaric acid (at two different doses), lisinopril alone, or a combination of both.

Untreated hypertensive rats showed significantly elevated activities of key enzymes linked to high blood pressure such as ACE, arginase, acetylcholinesterase, and phosphodiesterase-5 along with increased lipid peroxidation, an indicator of oxidative stress. At the same time, levels of nitric oxide, a critical molecule for blood vessel relaxation, were markedly reduced.

By contrast, rats treated with a combination of lisinopril and p-coumaric acid experienced notable improvements. Blood pressure was better controlled; harmful enzyme activities were reduced, oxidative stress declined, and nitric oxide levels increased. These improvements were mirrored in the tissues the heart compared with untreated hypertensive animals.

They said that the findings suggest that p-coumaric acid may enhance the antihypertensive action of lisinopril, potentially allowing for improved blood pressure control without increasing drug dosage.

This drug–food interaction model is particularly important in the circumstance of long-term hypertension management. Many patients rely on lifelong medication, and strategies that can improve treatment outcomes while reducing side effects are highly desirable.

The study also reinforces the growing recognition that diet is not merely supportive but can be biologically active in disease control.

The use of medicinal plants and plant-based therapies in the management of hypertension is deeply rooted in traditional medicine across many cultures. While such practices have often existed outside conventional healthcare systems, modern scientific research is now providing evidence-based explanations for their effectiveness.

While these findings are based on animal studies and cannot yet be directly translated into clinical recommendations for humans, they open the door to future research on dietary strategies that can safely complement antihypertensive drugs.

Further clinical studies are needed to determine appropriate dosages, safety profiles, and real-world effectiveness.

In the fight against hypertension, the future may lie not only in new drugs, but also in smarter combinations, where medicine and nutrition work together to deliver better, safer outcomes for patients.

Such nutrition to help maintain healthy blood pressure includes garlic, potatoes, walnuts,tomato and tomato products, legumes and citrus fruits (grapefruits and oranges).
(TRIBUNE)

News

Researchers Develop Treatment For Advanced Prostate Cancer

Published

10 hours ago

January 8, 2026

Editor

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.

The innovative approach, according to the researchers, targets prostate cancer cells just as successfully as existing treatments while causing significantly less harm to salivary glands.

For many people with prostate cancer, it relieves the extreme dry mouth that makes speaking, chewing, and swallowing nearly impossible.

According to the findings published in Molecular Imaging and Biology, the treatment targets PSMA (Prostate-Specific Membrane Antigen), a protein present in high numbers on prostate cancer cells.

Radioligand therapy (RTL) attaches radioactive material to a targeting molecule that acts like a GPS system, guiding the radiation directly to cancer cells while avoiding healthy tissue.

Current PSMA-targeted radioligand therapy is one of the most promising precision cancer treatments for end-stage prostate cancer because it acts as a “smart bomb” that locates and destroys cancer cells.

The downside, however, is that this therapy often causes severe salivary gland damage, resulting in extreme dry mouth that can be so debilitating that patients choose to stop treatment that might save their lives.

James P. Basilion, professor in the Department of Biomedical Engineering at Case Western Reserve and co-leader of the Cancer Imaging Program at the Case Comprehensive Cancer Centre (Case CCC), explained that various strategies to mitigate this side effect have been attempted before, with limited success.

According to the study, PSMA-1-DOTA has a four-fold greater affinity for prostate cancer cells than current therapies.

In addition to having the same tumour-fighting effectiveness as the current standard radioligand therapy, it also significantly reduced damage to the tear and salivary glands, almost eliminating the risk of dry mouth.

This discovery has the potential to significantly alter the treatment of prostate cancer by making PSMA-targeted therapy an earlier intervention rather than a “last resort.”

The research included comprehensive testing on mouse models and in a human patient with metastatic prostate cancer at the Technical University of Munich in Germany.

The patient study confirmed the lab findings, showing the new treatment avoided the salivary glands (potentially preventing dry mouth) while still finding and attacking prostate cancer cells.

The researchers, from now on, are preparing for clinical trials late this year on about 12 prostate patients to validate the promising results and establish the most effective dosing procedures.
(TRIBUNE)